Cargando…
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Despite the good responses of patients (pts) with stage III breast cancer to neoadjuvant chemotherapy (NAC), most eventually relapse and have a poor prognosis. We investigated the prognostic indicators in pts with stage III breast cancer treated with NAC, using epirubicin and/or docetaxel. A total o...
Autores principales: | TAKAHASHI, RYUJI, TOH, UHI, IWAKUMA, NOBUTAKA, MISHIMA, MAI, FUJII, TERUHIKO, TAKENAKA, MIKI, KOURA, KEIKO, SEKI, NAOKO, KAWAHARA, AKIHIKO, KAGE, MASHAYOSHI, OGO, ETSUYO, SHIROUZU, KAZUO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820806/ https://www.ncbi.nlm.nih.gov/pubmed/24223627 http://dx.doi.org/10.3892/etm.2013.1289 |
Ejemplares similares
-
FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
por: TAKENAKA, MIKI, et al.
Publicado: (2013) -
Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case
por: Muroya, Daisuke, et al.
Publicado: (2014) -
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
por: Takahashi, Ryuji, et al.
Publicado: (2014) -
Predictive factors of the tumor immunological microenvironment for long‐term follow‐up in early stage breast cancer
por: Okabe, Mina, et al.
Publicado: (2017) -
Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer
por: Mishima, Mai, et al.
Publicado: (2014)